首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
【24h】

Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.

机译:人类端粒酶逆转录酶(hTERT)mRNA表达增加,但端粒酶活性与治愈的非小细胞肺癌的生存有关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The purpose of this study was to evaluate the significance of human telomerase reverse transcriptase (hTERT) mRNA expression and telomerase activity as prognostic markers in non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: In a series of 69 curatively resected NSCLC specimens, telomerase activity was analyzed with the telomeric repeat amplification protocol (TRAP) assay and expression of hTERT mRNA by quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Partitioning of gene expression levels and protein activities to construct prognostic groups was attempted. RESULTS: Human hTERT mRNA transcripts were detected in 62 (89.9%) cases of NSCLC. Seven (10.1%) tumors were completely negative for hTERT expression. Dichotomized hTERT levels (<0.42 versus > or =0.42) were associated with prognosis and Kaplan-Meier survival curves demonstrated a significant difference (log rank: p<0.01) with 5-year survival rates of 44.3% (+/-7.1%) for low as compared to 80% (+/-8.9%) for high hTERT mRNA expression. Low hTERT expression was also significantly associated with squamous cell histology (p<0.03). Telomerase activity was not associated with survival, stage, pT and pN categories, histological type or grading. Comparison of hTERT mRNA expression and telomerase activity was possible in 66 patients and showed a significant difference (p<0.0001) by Wilcoxon rank test. CONCLUSION: This is the first study which demonstrates that high hTERT mRNA expression is associated with improved 5-year survival rates. Expression patterns are distinct among histopathological subtypes of NSCLC and telomerase activity (TRAP) is significantly higher than hTERT mRNA expression.
机译:背景:本研究的目的是评估人类端粒酶逆转录酶(hTERT)mRNA表达和端粒酶活性作为非小细胞肺癌(NSCLC)预后标志物的意义。患者和方法:在一系列69例经手术切除的NSCLC标本中,通过端粒重复扩增方案(TRAP)分析了端粒酶活性,并通过实时定量逆转录聚合酶链反应(RT-PCR)检测了hTERT mRNA的表达。试图对基因表达水平和蛋白质活性进行分区以构建预后组。结果:在62例(89.9%)非小细胞肺癌患者中检测到人类hTERT mRNA转录物。七个(10.1%)肿瘤的hTERT表达完全阴性。二分的hTERT水平(<0.42 vs>或= 0.42)与预后相关,Kaplan-Meier生存曲线显示出显着差异(对数秩:p <0.01),5年生存率达44.3%(+/- 7.1%) hTERT mRNA高表达的比例为80%(+/- 8.9%)。 hTERT的低表达也与鳞状细胞组织学显着相关(p <0.03)。端粒酶活性与存活率,阶段,pT和pN类别,组织学类型或分级无关。可以比较66例患者的hTERT mRNA表达和端粒酶活性,并通过Wilcoxon秩和检验显示出显着差异(p <0.0001)。结论:这是第一项证明hTERT mRNA高表达与5年生存率提高相关的研究。在NSCLC的组织病理学亚型中表达模式是不同的,端粒酶活性(TRAP)明显高于hTERT mRNA表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号